Laboratory of Genome Dynamics, Institute of Molecular Genetics of the Czech Academy of Sciences, 142 20, Prague 4, Czech Republic.
Faculty of Science, Charles University in Prague, 128 43, Prague 2, Czech Republic.
Nat Commun. 2022 Aug 26;13(1):5026. doi: 10.1038/s41467-022-32763-6.
Mutations in BRAT1, encoding BRCA1-associated ATM activator 1, have been associated with neurodevelopmental and neurodegenerative disorders characterized by heterogeneous phenotypes with varying levels of clinical severity. However, the underlying molecular mechanisms of disease pathology remain poorly understood. Here, we show that BRAT1 tightly interacts with INTS9/INTS11 subunits of the Integrator complex that processes 3' ends of various noncoding RNAs and pre-mRNAs. We find that Integrator functions are disrupted by BRAT1 deletion. In particular, defects in BRAT1 impede proper 3' end processing of UsnRNAs and snoRNAs, replication-dependent histone pre-mRNA processing, and alter the expression of protein-coding genes. Importantly, impairments in Integrator function are also evident in patient-derived cells from BRAT1 related neurological disease. Collectively, our data suggest that defects in BRAT1 interfere with proper Integrator functions, leading to incorrect expression of RNAs and proteins, resulting in neurodegeneration.
BRAT1 基因突变与神经发育和神经退行性疾病相关,这些疾病的表型具有异质性,临床严重程度不一。然而,疾病发病机制的潜在分子机制仍知之甚少。在这里,我们表明 BRAT1 与 Integrator 复合物的 INTS9/INTS11 亚基紧密相互作用,该复合物处理各种非编码 RNA 和前体 mRNA 的 3' 端。我们发现 Integrator 的功能被 BRAT1 缺失破坏。特别是,BRAT1 的缺陷会阻碍 UsnRNAs 和 snoRNAs 的正确 3' 端加工、复制依赖性组蛋白前体 mRNA 加工,并改变编码蛋白基因的表达。重要的是,BRAT1 相关神经疾病患者来源细胞中也存在 Integrator 功能缺陷。总之,我们的数据表明,BRAT1 的缺陷会干扰 Integrator 功能的正常发挥,导致 RNA 和蛋白质表达错误,从而导致神经退行性变。